The size of the global advanced infusion systems market is predicted to experience a CAGR of 6.2% from 2024 to 2029 and be worth USD 12.9 billion by 2029 from USD 9.55 billion in 2024.
The benefits associated with the advanced infusion systems, such as a rise in therapeutics effectiveness, safety, eliminating risks related to users, and enhanced bioavailability, are resulting in the increasing adoption of advanced infusion systems and contributing to the global market growth. The expansion of healthcare in various countries is leading to the increasing adoption of advanced infusion systems. It is likely to continue due to the rising prevalence of chronic diseases, which offers several growth opportunities for stakeholders in the region. Increased focus of governments in different nations for research and development activities boosts growth opportunities for the key players functioning in the advanced infusion systems market during the forecast period.
The growing healthcare spending is promoting the growth of the advanced infusion system market. The rise in the incidence of diabetes, cancer, and related gastrointestinal diseases, rising economies of emerging nations, and awareness regarding infusion systems among people are favoring the global advanced infusion systems market. The emergence of novel and innovative advanced infusion systems into the market creates lucrative growth opportunities for key market players in the advanced infusion systems market during the forecast period.
Risks associated with the systems due to improper training for operating are one of the significant restraints to the global advanced infusion systems market growth. Stringent laws and regulatory bodies are challenging the development of the advanced infusion systems market.
The COVID-19 outbreak has had a huge effect on people's lives all over the world. A medical device and associated disposables known as an advanced infusion system, are used to deliver drugs or fluids in solution to a patient. The medicine may be infused into the patient's body in various forms, including intravenous, arterial, subcutaneous, and epidural infusions, depending on the situation. There are different types of Advanced Infusion systems such as Infusion pumps, Intravenous Sets, IV Cannulas, and Needleless Connectors. The prevalence of lifestyle-related diseases such as diabetes, increased surgical rates, aesthetic use in pain management, pediatric neonate food availability, and the rise in cancer patients contribute to the market's rapid growth.
Because of the COVID-19 outbreak, the market for infusion pumps has skyrocketed. Hospitals are running out of infusion pumps to treat COVID-19 patients who need nebulization support due to a rise in the number of infections worldwide. As a result, governments are placing large orders with suppliers for thousands of infusion pumps. Due to the sudden increase in demand for infusion pumps, global and domestic players grow their production capacities to meet the demand, thus increasing growth prospects. As a result, Advanced Infusion Systems Market has had positive growth due to the COVID-19 pandemic.
REPORT METRIC |
DETAILS |
Market Size Available |
2023 to 2029 |
Base Year |
2023 |
Forecast Period |
2024 to 2029 |
Segments Covered |
By Application Type, Product Type, End Users, and Region |
Various Analyses Covered |
Global, Regional & Country Level Analysis, Segment-Level Analysis, Drivers, Restraints, Opportunities, Challenges, ROC, PESTLE Analysis, Porter’s Five Forces Analysis, Competitive Landscape, Analyst Overview on Investment Opportunities |
Regions Covered |
North America, Europe, APAC, Latin America, Middle East & Africa |
Key Market Players |
Hospira, AngioDynamics, Inc., Medtronic, Inc., Terumo Corporation, Johnson & Johnson, CareFusion Corporation, Animas Corporation, Baxter International, Inc., B. Braun Melsungen AG, I-Flow Corporation, and F. Hoffmann-La Roche Ltd. |
The diabetes segment is expected to dominate the global advanced infusion systems market. It is likely to grow rapidly during the forecast period due to the high prevalence of diabetic patients worldwide and the increasing demand for insulin pumps in-home care settings.
The chemotherapy market segment contributes a significant share of revenues to the advanced infusion systems market due to the increasing prevalence of cancer and the rising adoption rate of infusion systems in emerging countries.
The hospitals and ambulatory surgical centers segment is estimated to contribute the largest share to the advanced infusion systems market and is likely to grow significantly over the forecast period due to the factors such as the availability of technologically enhanced infusion systems in hospitals and the availability of trained professionals.
North America commands the most significant segment of the global advanced infusion systems market. In 2023, North America accounted for the largest share, with 48.7% of the market, followed by Europe, Asia-Pacific, Latin America, and the Middle East and Africa. It is mainly because of the high adoption of ambulatory pumps in managing chronic diseases, the high prevalence of rising penetration of advanced infusion systems, chronic diseases, and well-established healthcare infrastructure in the region. Asia-Pacific countries, particularly China and India) are expected to offer substantial growth opportunities for market players in the forecast period. Owing to the vast patient population, increasing incidence of chronic diseases with changing lifestyles, improving healthcare facilities, increasing accessibility to advanced products, and increasing disposable income.
Companies leading the global advanced infusion systems market profiled in the report are Hospira, AngioDynamics, Inc., Medtronic, Inc., Terumo Corporation, Johnson & Johnson, CareFusion Corporation, Animas Corporation, Baxter International, Inc., B. Braun Melsungen AG, I-Flow Corporation, and F. Hoffmann-La Roche Ltd.
By Application Type
By Product Type
By End-Users
By Region
Frequently Asked Questions
The increasing prevalence of chronic diseases, growing aging population, and advancements in medical technology are the key factors driving the growth of the advanced infusion systems market.
The high cost of advanced infusion systems, concerns over patient safety and efficacy of the devices, and stringent regulatory requirements are some of the challenges faced by the advanced infusion systems market.
Some of the key players in the advanced infusion systems market include Becton, Dickinson and Company, Fresenius SE & Co. KGaA, ICU Medical, Inc., Medtronic plc, and Smiths Medical.
Related Reports
Access the study in MULTIPLE FORMATS
Purchase options starting from $ 1800
Didn’t find what you’re looking for?
TALK TO OUR ANALYST TEAM
Need something within your budget?
NO WORRIES! WE GOT YOU COVERED!
Call us on: +1 888 702 9696 (U.S Toll Free)
Write to us: [email protected]
Reports By Region